Home › Funds › 22NW, LP › ELDN
22NW, LP position in ELDN
ELEDON PHARMACEUTICALS INC · Health Care
22NW, LP reported holding 636,364 shares of ELDN (ELEDON PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 1.12% of its reported portfolio and ranking #13 among its reported holdings. 22NW, LP has disclosed ELDN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How 22NW, LP's ELDN position evolved
22NW, LP first disclosed a stake in ELDN in Q1 2025 at 636,364 shares (US$2.2M). The position peaked in Q2 2026 at 636,364 shares, worth US$2.5M. Across 7 filings, 22NW, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 636,364 shares valued at US$1.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 636.36K | $2.16M | New |
| Q2 2025 | 636.36K | $1.72M | Hold |
| Q3 2025 | 636.36K | $1.65M | Hold |
| Q4 2025 | 636.36K | $960.91K | Hold |
| Q1 2026 | 636.36K | $1.96M | Hold |
| Q2 2026 | 636.36K | $2.51M | Hold |
| Q3 2026 | 636.36K | $1.61M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELDN and 13F data
ELDN (ELEDON PHARMACEUTICALS INC) is a Health Care company. 37 other funds we track also report a position in ELDN — the largest reported positions include BVF INC/IL (US$24.8M), Defilade Capital Management, L.P. (US$13.9M), Catalio Capital Management, LP (US$6.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELDN
- BVF INC/IL 6.29M sh · $24.80M · Q2 2026
- Defilade Capital Management, L.P. 3.53M sh · $13.89M · Q2 2026
- Catalio Capital Management, LP 1.70M sh · $6.68M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 1.19M sh · $4.69M · Q2 2026
- CM Management, LLC 525.00K sh · $1.33M · Q3 2026
FAQ
How long has 22NW, LP held ELDN?
22NW, LP has disclosed ELDN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is 22NW, LP's current position in ELDN?
As of Q3 2026, 22NW, LP holds 636.36K shares of ELDN (ELEDON PHARMACEUTICALS INC), valued at $1.61M, representing 1.12% of its reported portfolio and ranking #13.
Has 22NW, LP been buying or selling ELDN?
In the latest 13F filing (Q3 2026), 22NW, LP held unchanged its position in ELDN. The position peaked in Q2 2026 at 636.36K shares.
Which other funds hold ELDN?
Other major institutional holders of ELDN include BVF INC/IL, Defilade Capital Management, L.P., Catalio Capital Management, LP, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.